PATENT CLAIM ANALYSIS

Application Number: 15885987
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "332000"]

Abstract:
Disclosed herein are methods of reducing muscle contraction in a diaphragm or peripheral muscle(s) of a patient sufficient to permit a surgical procedure. The methods may comprise the step of administering an oxime or pharmaceutically acceptable salt thereof to a subject in need thereof in an amount sufficient to achieve said reduced muscle contraction/neuromuscular blockade. Kits and articles of manufacture comprising a container having a label and a composition are also disclosed.

Claim (Index 7):
The method of  claim 1 , wherein said oxime is administered via a route selected from intravenously, parenterally, intramuscularly, or a combination thereof.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15842823', '13612691', '12780644', '12439070', '14839432']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7012315038815495
- 35 USC 102 Novelty (BERT): 0.5108073506538162
- Combined Prediction Score: 0.6821890885587761
- Mean Citation Score: 165.921312
- Max Citation Score: 191.02849
- Similarity Product: 114.1157306576687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test